Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. (XENE) Stock Overview

Explore Xenon Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.

XENE●NASDAQ
HealthcareBiotechnology
$60.77
$1.04(1.74%)
U.S. Market opens in NaNh NaNm

Xenon Pharmaceuticals Inc. (XENE)

Meyka AI Score

Z

Key Financials

Market Cap5.9B
P/E Ratio-12.89
EPS (TTM)$-4.70
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$63.63
3 Months$82.43
1 Year Target$58.84

XENE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Xenon Pharmaceuticals Inc. (NASDAQ: XENE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Xenon Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of XENE on the NASDAQ shows an RSI of 42.39, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $58.84 for the NASDAQ listing.

Key metrics behind Xenon Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of -12.89 and a market capitalization of 5.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of XENE on the NASDAQ.

Price Performance (NASDAQ: XENE)

1-Day Change
1.74%
5-Day Change
-4.45%
1-Month Change
-8.95%
3-Month Change
12.29%
6-Month Change
43.90%
Year-to-Date (YTD) Change
35.59%
1-Year Change
59.17%
3-Year Change
59.63%
5-Year Change
265.20%
All-Time (Max) Change
478.76%

Contact Information

https://www.xenon-pharma.com
16044843300
3650 Gilmore Way, Burnaby, BC, V5G 4W8

Company Facts

3,640 Employees
IPO DateNov 5, 2014
CountryCA
Actively Trading

Frequently Asked Questions